CN Patent

CN112274493A — 一种哌柏西利胶囊的制备方法

Assigned to CSPC Zhongqi Pharmaceutical Technology Shijiazhuang Co Ltd · Expires 2021-01-29 · 5y expired

What this patent protects

本发明提供了一种干法造粒的方法，通过选择合适的细粉比例范围，提高了哌柏西利胶囊制备过程中得到的总混颗粒的含量均匀度，并且解决哌柏西利胶囊每个取样时间点溶出均一性差的问题。

USPTO Abstract

本发明提供了一种干法造粒的方法，通过选择合适的细粉比例范围，提高了哌柏西利胶囊制备过程中得到的总混颗粒的含量均匀度，并且解决哌柏西利胶囊每个取样时间点溶出均一性差的问题。

Drugs covered by this patent

Patent Metadata

Patent number
CN112274493A
Jurisdiction
CN
Classification
—
Expires
2021-01-29
Drug substance claim
No
Drug product claim
No
Assignee
CSPC Zhongqi Pharmaceutical Technology Shijiazhuang Co Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.